Akiko Hatori Selected Research

Akiko Hatori Research Topics

Disease

11	Neoplasms (Cancer) 02/2015 - 01/2005
10	Neuroinflammatory Diseases 01/2021 - 11/2007
10	Breast Neoplasms (Breast Cancer) 02/2019 - 04/2009
6	Central Nervous System Diseases (CNS Diseases) 01/2019 - 10/2012
5	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 11/2007
5	Schizophrenia (Dementia Praecox) 01/2020 - 01/2017
5	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2019 - 11/2007
4	Ischemia 01/2021 - 06/2010
3	Substance-Related Disorders (Drug Abuse) 01/2020 - 01/2018
3	Inflammation (Inflammations) 01/2018 - 03/2012
3	Pneumonia (Pneumonitis) 01/2016 - 09/2011
3	Human Influenza (Influenza) 05/2011 - 02/2008
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2016
2	Brain Diseases (Brain Disorder) 01/2020 - 04/2018
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016 - 11/2015
2	Non-alcoholic Fatty Liver Disease 01/2016 - 11/2012
2	Melanoma (Melanoma, Malignant) 02/2015 - 10/2014
2	Infarction (Infarctions) 01/2015 - 01/2011
2	Huntington Disease (Huntington's Disease) 04/2014 - 05/2011
1	Stroke (Strokes) 01/2021
1	Obesity 01/2019
1	Epilepsy (Aura) 09/2018
1	Status Epilepticus (Complex Partial Status Epilepticus) 11/2017
1	Glioma (Gliomas) 11/2017
1	Food Addiction 09/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2017
1	Pain (Aches) 01/2016
1	Fibrosis (Cirrhosis) 11/2015
1	Neoplasm Metastasis (Metastasis) 10/2014
1	Carcinogenesis 10/2014
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2012
1	Acute Lung Injury 01/2012

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2007
14	LigandsIBA 01/2019 - 11/2007
10	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2019 - 04/2009
6	Glutamic Acid (Glutamate)FDA Link 01/2019 - 07/2013
6	Biomarkers (Surrogate Marker)IBA 04/2018 - 11/2009
5	metabotropic glutamate receptor type 1IBA 11/2017 - 10/2012
4	acetamideIBA 11/2017 - 10/2009
3	metabotropic glutamate receptor 2IBA 01/2020 - 01/2017
3	ElacridarIBA 02/2019 - 11/2010
3	Phosphates (Orthophosphate)IBA 05/2011 - 02/2008
3	Oseltamivir (Tamiflu)FDA Link 05/2011 - 02/2008
3	Ro 64-0802IBA 05/2011 - 02/2008
3	GABA-A Receptors (GABA(A) Receptor)IBA 01/2010 - 11/2007
2	Monoacylglycerol LipasesIBA 01/2021 - 10/2019
2	Neuroprotective AgentsIBA 01/2021 - 09/2013
2	AcidsIBA 09/2018 - 01/2011
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 11/2017 - 10/2012
2	Carbon-11IBA 07/2016 - 04/2010
2	N-methylbenzamideIBA 10/2014 - 09/2013
2	PK 11195 (PK11195)IBA 11/2012 - 10/2009
2	LipopolysaccharidesIBA 01/2012 - 09/2011
2	Gefitinib (Iressa)FDA Link 04/2010 - 04/2009
2	EsterasesIBA 01/2009 - 02/2008
1	SAR127303IBA 01/2021
1	Minocycline (Cyclops)FDA LinkGeneric 01/2021
1	xanomelineIBA 01/2019
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2019
1	2- (4,5- dihydro- 1H- imidazol- 2- yl)- 1- methyl- 1H- indoleIBA 01/2019
1	AMPA Receptors (AMPA Receptor)IBA 09/2018
1	2- (7- butyl- 2- (4- (2- (((18)F)fluoroethoxy)phenyl)- 5- methylpyrazolo(1,5- a)pyrimidin- 3- yl)- N,N- diethylacetamideIBA 04/2018
1	Therapeutic UsesIBA 04/2018
1	N,N-diethylacetamideIBA 04/2018
1	EndocannabinoidsIBA 01/2018
1	Pilocarpine (Ocusert)FDA LinkGeneric 11/2017
1	Glucose (Dextrose)FDA LinkGeneric 09/2017
1	Ghrelin ReceptorsIBA 09/2017
1	cupric chloride (copper(II) chloride)FDA Link 01/2017
1	BuffersIBA 01/2017
1	PSMA-617IBA 01/2017
1	AntigensIBA 01/2017
1	SolutionsIBA 01/2017
1	Copper-64IBA 01/2017
1	Amyloid (Amyloid Fibrils)IBA 07/2016
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 07/2016
1	Peptides (Polypeptides)IBA 07/2016
1	anandamide (arachidonylethanolamide)IBA 01/2016
1	alpha-SynucleinIBA 01/2016
1	CannabinoidsIBA 01/2016
1	Carbon Tetrachloride (Tetrachloromethane)IBA 11/2015
1	Oncogene Proteins (Oncogene Protein)IBA 10/2014
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 08/2014
1	Phosphotransferases (Kinase)IBA 08/2014
1	agerafenibIBA 08/2014
1	N- methyl- N- (1- phenylethyl)- 2- propynylamineIBA 05/2014
1	nasIBA 11/2012
1	Choline (Choline Chloride)IBA 11/2012
1	Methionine (L-Methionine)FDA Link 11/2012
1	Messenger RNA (mRNA)IBA 03/2012
1	CytokinesIBA 03/2012
1	N- benzyl- N- methyl- 2- (7,8- dihydro- 7- (2- fluoroethyl)- 8- oxo- 2- phenyl- 9H- purin- 9- yl)acetamideIBA 01/2012
1	Topotecan (Hycamtin)FDA LinkGeneric 07/2011
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 07/2011
1	Imidazoline ReceptorsIBA 05/2011
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 04/2011
1	Sorafenib (BAY 43-9006)FDA Link 04/2011
1	Synaptotagmin IIBA 04/2011

Therapy/Procedure

4	Therapeutics 01/2021 - 04/2009
3	Drug Therapy (Chemotherapy) 01/2021 - 06/2010